Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02688036
PHASE3

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether hypofractionated concurrent chemo-radiotherapy has the same efficiency as conventionally fractionated concurrent chemo-radiotherapy in Limited Disease Small Cell Lung Cancer.

Official title: Phase III Randomized Study of Hypofractionated vs Conventionally Fractionated Concurrent Chemo-radiotherapy for Limited Disease Small Cell Lung Cancer

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

860

Start Date

2016-02

Completion Date

2023-12

Last Updated

2026-05-29

Healthy Volunteers

No

Interventions

RADIATION

hypofractionated concurrent chemoradiotherapy

For patients with Limited Disease Small Cell Lung Cancer, 45Gy/15F of radiotherapy with concurrent chemotherapy will be used in experimental arm.

RADIATION

conventionally fractionated concurrent chemoradiotherapy

For patients with Limited Disease Small Cell Lung Cancer, 60Gy/30F of radiotherapy with concurrent chemotherapy will be used in the control arm.

Locations (1)

Cancer Insititute and Hosiptal of Chinese Academy of Medical Sciences

Beijing, China